Skip to main content
Clinical Trials/ACTRN12612000086864
ACTRN12612000086864
Not yet recruiting
未知

Among patients with poorly controlled Type II diabetes will remote access to clinical care supported by the National Broadband Network (NBN) telehealth technologies, compared with usual diabetes care lead to improved diabetes control

Townsville Mackay Medicare Local (TMML)0 sites210 target enrollmentJanuary 17, 2012

Overview

Phase
未知
Intervention
Not specified
Conditions
Type II diabetes
Sponsor
Townsville Mackay Medicare Local (TMML)
Enrollment
210
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 17, 2012
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Townsville Mackay Medicare Local (TMML)

Eligibility Criteria

Inclusion Criteria

  • For a patient to be included in the trial:
  • Have a regular GP providing primary care
  • The practice should have a diabetes register (using Canning data extractor tool or equivalent)
  • Patients should:
  • Be diagnosed with type 2 Diabetes (not type 1\)
  • Live in a National Broadband Network (NBN) connected area in their home (not a residential aged care facility) \& be willing to connect to NBN at no cost
  • Be an adult, aged 18 years or over
  • Have recorded a HbA1c greater than or equal to 7\.5 % at any time in the previous 12 months (or if no result available, HbA1c greater than or equal to 7\.5 % when tested)

Exclusion Criteria

  • Patients should be excluded if they have any of the following conditions or characteristics:
  • Cancer (except non\-melanotic skin cancer) diagnosed in the previous 12 months
  • Palliative care
  • Intellectual and mental impairment (that would preclude use of technology)
  • Dementia (that would preclude use of technology)
  • Primary language other than English
  • Chronic kidney disease and on dialysis or likely to be on dialysis within the timeframe of the trial
  • Severe vision impairment (if deemed unable to use technology)
  • Severe unstable co\-morbidities as assessed by GP as unlikely to survive for the 12 month period of the trial
  • Current enrolment in another health intervention trial

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
EXERFLOW STUDY:The effects of aerobic and resistance exercise training on vascular endothelial function in people with type 2 diabetes mellitusType 2 diabetesVascular function (endothelial function)Metabolic and Endocrine - DiabetesCardiovascular - Diseases of the vasculature and circulation including the lymphatic system
ACTRN12609000799257Baker IDI Heart and Diabetes Institute45
Recruiting
Not Applicable
The role of Vitamin C in managing type 2 diabetes: Vitamin C, Thiazolidinediones and their combined effect onAdiponectiType 2 diabetesMetabolic and Endocrine - Diabetes
ACTRN12611000488909Princess Alexandra Hospital10
Recruiting
Not Applicable
Structured monitoring of blood glucose for people with non-insulin-treated type 2 diabetes: Structured Testing Program Implementation Trial – Updated Protocol (STeP IT UP)Type 2 diabetes mellitus (T2DM)Metabolic and Endocrine - Diabetes
ACTRN12613000927729Roche Diagnostics Australia145
Not yet recruiting
Not Applicable
A Comparison of Peri-Operative and Post Acute Coronary Syndrome Glycaemic Control in Insulin Requiring Patients with Type 2 Diabetes at St Vincent’s Hospital With and Without Real-Time Continuous Glucose Monitoring.Type 2 diabetes requiring insulinAcute coronary syndromesPost - operative patientsMetabolic and Endocrine - DiabetesCardiovascular - Coronary heart diseaseSurgery - Surgical techniques
ACTRN12608000125325St Vincent's Hospital60
Not yet recruiting
Phase 4
Molecular determinants of glucose sensing in human gastrointestinal tract of patients with type 2 diabetes and healthy volunteers.Type II DiabetesMetabolic and Endocrine - Diabetes
ACTRN12613000843752Dr. Nam Q Nguyen40